GUTS - NASDAQ

Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. Common Stock

GUTSยทNASDAQ

$0.76

-3.1%
HealthcareBiotechnology

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$54.87M
EPS-1.8600
P/E Ratio-0.41
Earnings Date08/11/2026
Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. Common Stock Fair Value Envelope

GUTS ยท NASDAQ

Our analysis suggests that GUTS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $0.76, this represents a potential HIDDEN relative to our calculated worth for Fractyl Health, Inc. Common Stock.

HIDDEN
Intrinsic Value
Current Price: $0.76

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$135.5M
+ Cash & Equivalents$81.5M
Firm Value-$53.9M
- Debt$61.6M
Equity Value-$115.6M
/ Shares Outstanding72,193,770B
DCF Value-$2
OVERVALUED BY 311%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$58.6M
-$38.1M
-$24.7M
-$16.1M
-$10.4M
-$6.8M
-$4.4M
-$2.9M
-$1.9M
-$1.2M
Maintenance CapEx
-$72.3K
-$47.0K
-$30.5K
-$19.8K
-$12.9K
-$8.3K
-$5.4K
-$3.5K
-$2.3K
-$1.5K
Owner Earnings
-$58.7M
-$38.1M
-$24.8M
-$16.1M
-$10.4M
-$6.8M
-$4.4M
-$2.9M
-$1.9M
-$1.2M
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$54.4M
-$32.7M
-$19.7M
-$11.8M
-$7.1M
-$4.3M
-$2.6M
-$1.5M
-$927.7K
-$557.7K
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your GUTS research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.